← All trials
NCT04785196
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 2, 2021
- Primary completion
- Apr 30, 2024
- Completion date
- Jan 31, 2025
- First posted
- Mar 5, 2021
- Last posted
- Sep 23, 2021
- Enrollment
- 92
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Ascentage Pharma Group Inc.Lead sponsor
- Huazhong University of Science and TechnologyOverall official - principal investigator
- Government of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.